Philip Young

Chief Executive Officer at LOBE SCIENCES LTD.

Net worth: 8 288 $ as of 30/05/2024

66 year

52 connections

Health Technology

Commercial Services

Consumer Services

Philip Young active positions

Companies	Position	Start	End
LOBE SCIENCES LTD.	Chairman	-	-
	Chief Executive Officer	14/01/2021	-
	Corporate Secretary	14/01/2021	-
	Director/Board Member	14/01/2021	-

Career history of Philip Young

Former positions of Philip Young

Companies	Position	Start	End
PANACEA LIFE SCIENCES HOLDINGS, INC.	Director/Board Member	28/02/2016	30/07/2019
	Chief Executive Officer	23/03/2016	30/07/2019
	Chairman	23/03/2016	11/02/2019
	Director of Finance/CFO	08/05/2019	09/07/2019
	Public Communications Contact	28/02/2016	-
	President	23/03/2016	08/01/2019
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Director/Board Member	30/09/2011	30/11/2014
	Chief Executive Officer	30/09/2011	30/11/2014
	President	30/09/2011	30/11/2014
OSTEOLOGIX HOLDINGS PLC	Director/Board Member	31/03/2007	12/07/2012
OSTEOLOGIX HOLDINGS PLC	Director of Finance/CFO	05/05/2010	-
WOODBROOK GROUP HOLDINGS INC.	Director/Board Member	-	18/11/2008
INSMED INCORPORATED	Corporate Officer/Principal	31/03/2004	06/03/2007
AGY Therapeutics, Inc. AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA.	Chief Operating Officer	31/12/1999	31/12/2003
	President	31/12/1999	31/12/2003
Gantech International, Inc.	President	31/12/1999	31/12/2003
Neurex Pharmaceuticals	Corporate Officer/Principal	31/12/1997	31/12/1999
░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░	░░░░░░░░░░	-
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	-	-
	░░░░░░░░	-	-
	░░░░░░░	-	-
	░░░░░░░░░	-	-
░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-	-

Training of Philip Young

James Madison University

Undergraduate Degree

Statistics

International

United States	11
Ireland	2
France	2

Operational

President	6
Director/Board Member	5
Chief Executive Officer	5

Sectoral

Health Technology	5
Commercial Services	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	3
INSMED INCORPORATED	Health Technology
WOODBROOK GROUP HOLDINGS INC.	Finance
LOBE SCIENCES LTD.	Process Industries

Private companies	9
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Health Technology
AGY Therapeutics, Inc. AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA.	Health Technology
Exactus, Inc. Exactus, Inc. Miscellaneous Commercial ServicesCommercial Services Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The firm's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company was founded in 2008 and is headquartered in Delray Beach, FL.	Commercial Services
Osteologix Holdings Plc Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland.	Health Technology
Pharmacia SAS
Gantech International, Inc.
Neurex Pharmaceuticals
Exactus Biosolutions, Inc. Exactus Biosolutions, Inc. Miscellaneous Commercial ServicesCommercial Services Exactus Biosolutions, Inc. operates as a life science company that develops and commercializes point-of-care diagnostics for measuring proteolytic enzymes in the blood based on a proprietary detection platform. The company was founded by Phillip J. Young and Timothy Ryan and is headquartered in New York, NY.	Commercial Services
TrippBio, Inc. TrippBio, Inc. Miscellaneous Commercial ServicesCommercial Services TrippBio, Inc. engages in biotechnology industry. The company is headquartered in Jacksonville, FL.	Commercial Services

See company connections